A study to investigate the safety of the drugs topiramate and levetiracetam in treating children recently diagnosed with epilepsy

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-001552-19

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to evaluate the effects of topiramate monotherapy compared with levetiracetam, another standard antiepileptic drug (AED), as monotherapy for new-onset or recent-onset epilepsy on pediatric growth and maturation, bone mineralization, and kidney stone formation in children 2 to 15 years of age.


Critère d'inclusion

  • New-onset or recent-onset epilepsy